Vilin Bio Med Limited
Updates
01 / The disclosure
What the company shared
Vilin Bio Med Limited has informed the Exchange that, being listed on the NSE Emerge Platform, the Company is exempt from the applicable Corporate Governance requirements. However, the Company is voluntarily submitting the Integrated Corporate Governance Report for the period ended September 30, 2026.
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
Disclosed period ended 2026-09-30 · Q2 FY2027The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106829981
- First collected
- 27 Oct 2026, 13:35 IST
- PDF extraction
- metadata_only